Biocon Hopes To Grab ‘Major’ Share Of $3-Billion Trastuzumab Market In U.S.: Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw, managing director and co-founder of Biocon Ltd. (Photographer: Samyukta Lakshmi/Bloomberg)

Biocon Hopes To Grab ‘Major’ Share Of $3-Billion Trastuzumab Market In U.S.: Kiran Mazumdar-Shaw

Biocon Ltd. hopes to make a “major impact” in the $3-billion market for Trastuzumab biosimilar in the U.S., Chairman and Managing Director Kiran Mazumdar-Shaw said a day after the drug’s launch.“Th...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.